Montelukast 5mg Chewable Tablet
Reviewed educational reference: what Montelukast is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Montelukast
- Strength
- 5mg
- Dosage form
- Chewable Tablet
- Drug class
- Leukotriene Receptor Antagonist
Related products
No reviewed products are currently published for this generic.
Montelukast 5mg Chewable Tablet is a specialized medication containing Montelukast, which is used for the long term management of asthma and allergic rhinitis. Unlike rescue inhalers, Montelukast 5mg Chewable Tablet does not provide immediate relief during an acute asthma attack. Instead, it works by blocking the action of leukotrienes, which are chemicals the body releases that cause airway swelling and mucus production. This makes Montelukast 5mg Chewable Tablet an effective choice for preventing symptoms and reducing the frequency of asthma flares in children and adults. It is often prescribed as a maintenance therapy to keep the airways open and reduce the need for other medications.
At a glance
Montelukast 5mg Chewable Tablet is a chewable tablet containing 5mg of Montelukast.
It blocks leukotriene receptors to reduce airway inflammation and mucus.
It is used for the long term prevention of asthma and allergic rhinitis.
Uses of Montelukast
- Prophylaxis and chronic treatment of asthma in children and adults.
- Management of exercise induced bronchoconstriction to prevent shortness of breath during physical activity.
- Treatment of seasonal allergic rhinitis to reduce sneezing and itching.
- Management of perennial allergic rhinitis for year round allergy relief.
- Reduction of the need for oral corticosteroids in patients with persistent asthma.
- Control of airway inflammation to improve overall lung function and quality of life.
Benefits of Montelukast
Long Term Airway Stability
By consistently blocking leukotriene receptors, Montelukast 5mg Chewable Tablet helps maintain open airways. This reduces the likelihood of sudden asthma attacks and allows patients to engage in daily activities with less fear of breathlessness.
Steroid Sparing Effect
For many patients, adding Montelukast to their regimen allows the doctor to lower the dose of inhaled or oral corticosteroids. This is beneficial because it reduces the risk of steroid related side effects like growth retardation in children or bone density loss in adults.
Side effects of Montelukast
Most people tolerate Montelukast 5mg Chewable Tablet well, but some may experience side effects. Common issues include mild headaches, stomach pain, or a feeling of nausea. Some patients report a cough or a sore throat. A more serious concern is the possibility of neuropsychiatric events. These can include mood changes, irritability, aggression, or sleep disturbances. In rare cases, patients may experience liver enzyme elevations or severe allergic reactions such as swelling of the face or throat. If you notice any sudden changes in behavior or mood, you must inform your healthcare provider immediately, as these reactions can be severe in some individuals.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Headache | Common | Mild | Take a mild analgesic if needed. |
| Neuropsychiatric events | Uncommon | Moderate | Stop the drug and contact a doctor. |
| Abdominal pain | Common | Mild | Take the medication with a small snack. |
How to manage side effects
Headache
- Rest in a quiet room
- Stay hydrated
- Consult doctor if persistent
Neuropsychiatric events
- Immediate clinical evaluation
- Psychological support
- Switch to alternative therapy
Abdominal pain
- Avoid heavy meals immediately after
- Monitor for nausea
- Report severe pain to doctor
How to use Montelukast
- Chew the tablet completely before swallowing it. Do not swallow the tablet whole.
- Take Montelukast 5mg Chewable Tablet once daily, preferably in the evening.
- Maintain a consistent schedule every day to ensure the medication remains effective.
- Do not stop taking the medication suddenly even if you feel better, as this may cause symptoms to return.
Special population advice
Kidney impairment
- No dose adjustment is required.
- Safe for use in patients with renal failure.
Liver impairment
- Use with caution in severe hepatic impairment.
- Monitor for signs of liver toxicity.
Children
- 5mg dose is typically for children aged 2 to 14 years.
- For children 6 months to 2 years, a 4mg dose is usually prescribed.
Elderly
- Standard adult dosing applies.
- Monitor for increased sensitivity to neuropsychiatric side effects.
How Montelukast works
Montelukast works by selectively blocking the CysLT1 receptor. Leukotrienes are inflammatory mediators that cause the muscles around the airways to tighten and increase mucus secretion. By blocking these receptors, Montelukast 5mg Chewable Tablet prevents bronchoconstriction and reduces inflammation in the lining of the lungs and nasal passages.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Montelukast 5mg Chewable Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one. Do not take two doses at the same time to make up for a forgotten tablet.
In case of overdose
Overdose of Montelukast is uncommon and usually does not cause life threatening toxicity. Symptoms may include extreme drowsiness, nausea, or agitation. If an overdose is suspected, seek medical help immediately and provide the packaging of Montelukast 5mg Chewable Tablet to the treating physician.
Treatment is supportive and symptomatic.
- Gastric Decontamination
- Activated charcoal may be considered if the overdose was recent and large.
- Observation
- Monitor vital signs and mental status for at least 6 to 12 hours.
- Symptomatic Care
- Provide fluids and manage any agitation or nausea as they appear.
- Neurological Assessment
- Assess for CNS depression or abnormal behavioral changes.
Safety and precautions
When to avoid Montelukast
- Hypersensitivity
Known allergy to montelukast sodium or any excipients in the tablet.
- Acute bronchospasm
Not to be used as primary rescue therapy for acute asthma attacks.
- Neuropsychiatric disorders
Patients with a history of depression, anxiety, or suicidal thoughts should be monitored closely.
- Hepatic impairment
Use with caution in patients with severe liver disease.
- Acute asthma attack
Must not be used as a substitute for rescue medication during an acute episode.
- Pregnancy
Use only if clearly needed and under strict medical supervision.
Safety at a glance
Avoid alcohol as it may increase the risk of drowsiness or mood changes.
Consult your doctor to weigh the benefits against potential risks to the fetus.
Use with caution. Consult a physician as data on excretion in human milk is limited.
Be careful if you experience mood changes or drowsiness before driving.
No dose adjustment is typically required for patients with kidney impairment.
Use with care in patients with liver disease. Monitor liver function tests if needed.
Do not take if you have a known hypersensitivity to montelukast or its components.
Safe for children 6 months and older with appropriate weight based dosing.
No specific dose adjustments are needed for elderly patients.
Interactions
With other medicines
Phenobarbital
ModerateChanges how the medicine is processed
What can happen: Decreased plasma levels of montelukast.
What to do: Monitor for reduced efficacy of asthma control.
Rifampicin
ModerateChanges how the medicine is processed
What can happen: Increased metabolism of montelukast.
What to do: Adjust dose of montelukast if symptoms worsen.
Theophylline
MinorChanges the medicine’s effect
What can happen: Additive effect on airway relaxation.
What to do: Routine monitoring of respiratory function.
With food and drink
- Grapefruit juiceMinor
May slightly alter the metabolism of the drug but is generally not clinically significant.
- St. John's wortModerate
May decrease blood levels of montelukast by inducing CYP3A4 enzymes.
If you have another condition
- Severe Liver Disease
May require closer monitoring of drug effects due to hepatic metabolism.
- Clinical Depression
Increased risk of worsening mood or developing suicidal ideation.
Effect on laboratory tests
- Liver Function Tests (LFT)
Possible increase
Rare elevations in ALT or AST may occur during treatment.
Quick tips
- Remember that Montelukast 5mg Chewable Tablet is a preventive medicine. It will not stop an asthma attack that has already started. Always keep your rescue inhaler with you.
- Watch for changes in mood or behavior, especially in children. Report any unusual aggression or anxiety to your doctor.
- Keep a symptom diary to track how often you use your rescue inhaler while taking Montelukast 5mg Chewable Tablet.
- Avoid starting new medications or supplements without consulting your doctor, as some drugs can affect how Montelukast works.
Counselling points
- Rescue MedicationImportant
Always carry your rescue inhaler. Montelukast 5mg Chewable Tablet will not stop a sudden attack.
- Mood ChangesImportant
Tell your doctor immediately if you feel unusually sad, angry, or anxious.
- AdministrationGood to know
Chew the tablet completely before swallowing it for best absorption.
- ConsistencyGood to know
Take your dose at the same time every evening to keep your lungs protected.
Pharmacokinetics
- Absorption
- Rapidly absorbed after oral administration.
- Bioavailability
- Approximately 64 percent.
- Protein binding
- Greater than 99 percent.
- Volume of distribution
- Not widely established in humans.
- Half-life
- 3 to 4 hours.
- Metabolism
- Extensively metabolized in the liver by CYP3A4.
- Excretion
- Primarily excreted in feces as metabolites.
- Onset / duration
- Onset of action is rapid, but therapeutic effect is maintained with once daily dosing.
Fact box
- Chemical class
- Quinoline derivative
- Habit forming
- No
- Therapeutic class
- Anti-asthmatic
- Action class
- CysLT1 Receptor Antagonist
- Storage
- Store Montelukast 5mg Chewable Tablet in its original blister pack at room temperature, away from moisture and direct sunlight. Keep it out of reach of children.
- ATC code
- R030203
- Pregnancy category
- C
More information
Why Clinicians Prefer Montelukast in Pediatrics
In pediatric practice, the administration of inhaled corticosteroids often presents a challenge. Many young children struggle with the coordination required for metered dose inhalers or the seal needed for dry powder inhalers. Even with spacers, the technique can be imperfect. This is where Montelukast 5mg Chewable Tablet offers a significant advantage. As a chewable tablet, it removes the technical barrier of inhalation. Clinicians often pick Montelukast as a first line add on therapy because it is easy for parents to administer and ensures the child receives the full dose. Furthermore, for children whose asthma is triggered by exercise or allergies, the oral route provides a systemic block of leukotrienes that is highly effective in reducing nighttime coughing and improving sleep quality, which is a major concern for both the child and the parents.
Comparing LTRAs with Inhaled Corticosteroids
While inhaled corticosteroids are the gold standard for persistent asthma, leukotriene receptor antagonists like Montelukast serve a different but complementary role. Corticosteroids act broadly on many inflammatory pathways, whereas Montelukast 5mg Chewable Tablet specifically targets the leukotriene pathway. This makes it particularly useful for patients with the asthma allergy overlap syndrome. Some patients find that they do not respond fully to steroids alone, or they may experience local side effects like oral thrush. In such cases, Montelukast 5mg Chewable Tablet is used to provide additional control. It is also preferred for exercise induced bronchoconstriction because it can be taken hours before activity to prevent the narrowing of airways. However, it is rarely used as a sole therapy for severe asthma and is most effective when used as part of a stepped care approach.
Lifestyle and Environmental Management
Taking Montelukast 5mg Chewable Tablet is only one part of managing asthma and allergies. To get the most out of the medication, patients must focus on trigger avoidance. This includes using dust mite proof covers on mattresses and pillows, keeping indoor humidity low to prevent mold, and avoiding strong perfumes or smoke. For those with seasonal allergies, keeping windows closed during high pollen counts and using saline nasal sprays can reduce the load on the immune system. A diet rich in omega 3 fatty acids and antioxidants may also help reduce systemic inflammation. Patients are encouraged to maintain a healthy weight, as obesity can worsen asthma control and make the lungs less responsive to medications. Combining Montelukast with these lifestyle changes often leads to a significant reduction in the number of rescue inhaler puffs needed per week.
What to Expect During Treatment
Patients starting Montelukast 5mg Chewable Tablet should understand that this is a marathon, not a sprint. Unlike a bronchodilator that opens the lungs in minutes, Montelukast works by gradually reducing the inflammation and sensitivity of the airways. Most patients begin to feel a difference in their breathing and a reduction in allergy symptoms within one to two weeks. Over several months, the goal is to reach a state of stability where asthma attacks are rare and sleep is uninterrupted. It is common for doctors to review the dose every few months to see if the patient can move to a lower step of therapy. Patients should be warned that stopping the medication abruptly can lead to a return of symptoms. Consistency is the key to success with this therapy, and the long term goal is always to maintain a high quality of life with minimal medication interference.
References
- Electronic Medicines Compendium. Montelukast Sodium, Summary of Product Characteristics.View sourceAccessed
- STADA. Montelukast 5 mg chewable tablet, Summary of Product Characteristics.View sourceAccessed
- Rwanda FDA. Montemac 5 Montelukast Sodium USP 5mg Chewable Tablets, SmPC.View sourceAccessed
- Bristol Laboratories. Montelukast 5mg chewable tablets, Summary of Product Characteristics.View sourceAccessed
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
Frequently asked questions about Montelukast
Can I use this tablet to stop a sudden asthma attack?
No, Montelukast 5mg Chewable Tablet is a maintenance medication. It prevents attacks but cannot stop one that is already happening. Use your rescue inhaler for acute symptoms.
Why do I have to chew the tablet?
The chewable form ensures that the medication is absorbed correctly and is easier for children to take than swallowing a large pill.
How long does it take for Montelukast 5mg Chewable Tablet to start working?
You may notice an improvement in symptoms within a few days, but the full preventive benefit often takes a few weeks of consistent use.
Can I take this medicine if I have a cold?
Yes, you can continue taking Montelukast 5mg Chewable Tablet during a cold. In fact, viral infections often trigger asthma, making maintenance therapy even more important.
What should I do if my child becomes irritable while taking this?
Contact your pediatrician immediately. Neuropsychiatric changes are known side effects and may require a change in medication.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →